SiRNA-mediated silencing of CDK8 inhibits proliferation and growth in breast cancer cells

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 1, 2014, Pages 92-100

  Li, Xiao Yu ^a   Luo, Qi Feng ^a   Wei, Chuan Kui ^a   Li, Deng Feng ^a   Fang, Lin ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Breast cancer; CDK8; SiRNA

Indexed keywords

CDK8 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 8; SMALL INTERFERING RNA;

ARTICLE; BIOSYNTHESIS; BREAST CANCER; BREAST TUMOR; CDK8; CELL PROLIFERATION; CELL TRANSFORMATION; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BREAST CANCER; CDK8; SIRNA;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE 8; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84891753703     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Smolarek AK, Suh N. Chemopreventive activity of vitamin E in breast cancer: a focus on gamma- and delta-tocopherol. Nutrients 2011; 3: 962-986.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J Clin 2012; 62: 10-29.
3. Liu X, Jiang F, Kalidas S, Smith D, Liu Q. Dicer-2 and R2D2 coordinately bind siRNA to promote assembly of the siRISC complexes. RNA 2006; 12: 1514-1520.
4. Størvold GL, Andersen TI, Perou CM, Frengen E. siRNA: a potential tool for future breast cancer therapy? Crit Rev Oncog 2006; 12: 127-150.
5. Adler AS, McCleland ML, Truong T, Lau S, Modrusan Z, Soukup TM, Roose-Girma M, Blackwood EM and Firestein R. CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency. Cancer Res 2012; 72: 2129-2139.
6. Gu W, Wang C, Li W, Hsu FN, Tian L, Zhou J, Yuan C, Xie XJ, Jiang T, Addya S, Tai Y, Kong B and Ji JY. Tumor-suppressive effects of CDK8 in endometrial cancer cells. Cell Cycle 2013; 12: 987-999.
7. Adler AS, Mccleland ML, Truong T. CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency. Cancer Res 2012; 72: 2129-2139.
8. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M and Hahn WC. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008; 455: 547-551.
9. Gu W, Wang C, Li W, Hsu FN, Tian L, Zhou J, Yuan C, Xie XJ, Jiang T, Addya S, Tai Y, Kong B and Ji JY. Tumor-suppressive effects of CDK8 in endometrial cancer cells. Cell Cycle 2013; 12: 987-999.
10. Dang CM, Estrada S, Bresee C and Phillips EH. Exploring Potential Use of Internet, E-mail, and Instant Text Messaging to Promote Breast Health and Mammogram Use among Immigrant Hispanic Women in Los Angeles County. Am Surg 2013; 79: 997-1000.
11. Datta M and Schwartz GG. Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy. Crit Rev Oncol Hematol 2013; 88: 613-624.
12. Sharma PS, Sharma R and Tyagi R. Inhibitiors of cyclin depentent kinases: useful targets for cancer treatment. Curr Cancer Drug Targets 2008; 8: 53-75.
13. Senderowicz AM and Sausville EA. Preclinical and clinical development of cyclin-dependent kinase modulators. J Natl Cancer Inst 2000; 92: 376-387.
14. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M and Hahn WC. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008; 455: 547-551.
15. Firestein R, Shima K, Nosho K, Irahara N, Baba Y, Bojarski E, Giovannucci EL, Hahn WC, Fuchs CS and Ogino S. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival. Int J Cancer 2010; 126: 2863-2873.
16. Donner AJ, Szostek S, Hoover JM and Espinosa JM. CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol Cell 2007; 27: 121-133.
17. Fryer CJ, White JB and Jones KA. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 2004; 16: 509-520.